Descrição
Produtos
12 produtosBrand: Stivant. Bevacizumab biosimilar. Metastatic colorectal cancer, progressive glioblastoma, NSCLC, advanced or metastatic kidney cancer, epithelial ovarian, fallopian tube and primary peritoneal cancer, cervical cancer and metastatic breast cancer.
Produto acabado
Verificado a 2026-10-21
Brand: Artenix. Monoclonal IgG2 antibody binding RANKL. Indication not stated on the website.
Produto acabado
Verificado a 2026-10-21
Brand: Arylia. Human IgG2 monoclonal antibody binding RANKL. Osteoporosis (the website describes postmenopausal, male and treatment-related osteoporosis).
Produto acabado
Verificado a 2026-10-21
Brand: Aryxent. Monoclonal antibody blocking IL-4 and IL-13. Atopic dermatitis, asthma, eosinophilic esophagitis, chronic spontaneous urticaria, prurigo nodularis and COPD. Aryxent 200 and Aryxent 300 presentations.
Produto acabado
Verificado a 2026-10-21
Brand: Coageight. Recombinant coagulation factor VIII, Fc fusion protein, produced in CHO cells. Treatment and prevention of bleeding in haemophilia A, all age groups.
Produto acabado
Verificado a 2026-10-21
Brand: Altebrel. Etanercept biosimilar, TNF-blocking fusion protein produced in CHO cells. Rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis-related arthritis and plaque psoriasis. Prefilled syringes 25 mg and 50 mg.
Produto acabado
Verificado a 2026-10-21
Brand: Rheuflix. Contains infliximab; chronic inflammatory diseases, particularly rheumatoid arthritis.
Produto acabado
Verificado a 2026-10-21
Brand: AryoSeven. Glycoprotein produced in BHK cells by recombinant technology. Control, treatment and prevention of bleeding in congenital haemophilia A or B with inhibitors, acquired haemophilia, congenital factor VII deficiency and Glanzmann's thrombasthenia. Marketed as 1.2 mg (60 KIU), 2.4 mg (120 KIU) and 4.8 mg (240 KIU) lyophilised powder for injection.
Registo submetido
Produto acabado
Verificado a 2026-10-21
Brand: Zytux. Rituximab biosimilar, chimeric monoclonal antibody produced in CHO cells. Non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, GPA and MPA, pemphigus vulgaris. 100 mg and 500 mg vials for infusion.
Produto acabado
Verificado a 2026-10-21
Brand: Temziva. Contains tocilizumab (IL-6 blocker). Cytokine release syndrome (CRS) in adults and children aged 2 and older with confirmed COVID-19. 400 mg/20 mL vial.
Registo submetido
Produto acabado
Verificado a 2026-10-21
Brand: AryoTrust. Trastuzumab biosimilar produced in recombinant CHO cells. HER2-overexpressing early and metastatic breast cancer and metastatic gastric cancer. Lyophilised powder for infusion, 150 mg and 440 mg.
Produto acabado
Verificado a 2026-10-21
Brand: VedAryo. Humanized IgG1 monoclonal antibody binding integrin α4β7, produced in CHO cells.
Produto acabado
Verificado a 2026-10-21
Contactar empresa
Registe-se gratuitamente para ver os dados de contacto desta empresa e escrever-lhe.
Registar - Gratuito